Unlisted biotech firm CureVac on Wednesday become the second company after rival BioNTech to launch human trials of an experimental coronavirus vaccine in Germany, eyeing potential regulatory approval in mid-2021.

German biotech firm starts human trials of experimental COVID-19 vaccine | WION-DW Partnership

corona-vaccine-human-trials

Corona Vaccine Human Trials, News on Corona Vaccine Human Trials, stories on Corona Vaccine Human Trials, articles on Corona Vaccine Human Trials, Corona Vaccine Human Trials stories at Wion, Corona Vaccine Human Trials news, Corona Vaccine Human Trials latest news

corona vaccine-human-trials

German biotech firm starts human trials of experimental COVID-19 vaccine | WION-DW Partnership